Sidra Medicine to host RAPID 2026 conference in September

Doha, Qatar: Sidra Medicine, part of Qatar Foundation, will host the RAPID 2026 conference from September 25 to 27, 2026. This gathering of international experts, clinicians, researchers, and healthcare professionals will focus on the latest developments in diagnosing, managing, and researching primary and genetic immune dysregulation disorders.

The event, themed "Frontiers in Diagnostics for Primary Immunodysregulation Disorders," will include scientific presentations, multidisciplinary debates, and a Master Class on Inborn Errors of Immunity at Sidra Medicine.

Organized jointly by The Isil Berat Barlan Academy (IBB) and the Universal Scientific Education and Research Network (USERN), the conference aims to bolster regional and global cooperation while advancing precision diagnostics and patient care. Dr. Bernice Lo, principal investigator and co-chair of the conference, highlighted that the event underscores Sidra Medicine's dedication to advancing research and enhancing outcomes for patients with rare and complex immune disorders.

Dr. Mohammed Yousuf Karim, division chief of Hematology and co-chair of the conference, emphasized that the field of immune dysregulation is advancing swiftly, propelled by progress in genomics, diagnostics, and translational research. RAPID 2026 will serve as a crucial platform for clinicians and scientists to share recent findings, discuss intricate clinical cases, and help establish future standards of care for patients across the region and beyond.